国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe Autophagy protein 5 (atg5) CSB-YP002293SXV
CSB-EP002293SXV
CSB-BP002293SXV
CSB-MP002293SXV
CSB-EP002293SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Conserved oligomeric Golgi complex subunit 4 (cog4), partial CSB-YP005708SXV
CSB-EP005708SXV
CSB-BP005708SXV
CSB-MP005708SXV
CSB-EP005708SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spodoptera frugiperda Casein kinase II subunit alpha CSB-YP006072FKQ
CSB-EP006072FKQ
CSB-BP006072FKQ
CSB-MP006072FKQ
CSB-EP006072FKQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anopheles gambiae Adenosylhomocysteinase (Ahcy13) CSB-YP001474BZL
CSB-EP001474BZL
CSB-BP001474BZL
CSB-MP001474BZL
CSB-EP001474BZL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acarus siro Fatty acid-binding protein CSB-YP007956AVU
CSB-EP007956AVU
CSB-BP007956AVU
CSB-MP007956AVU
CSB-EP007956AVU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brugia malayi Protein JTB (JTB), partial CSB-YP011970BWV
CSB-EP011970BWV
CSB-BP011970BWV
CSB-MP011970BWV
CSB-EP011970BWV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Eukaryotic translation initiation factor 3 subunit E (eIF3-S6) CSB-YP007534DLU
CSB-EP007534DLU
CSB-BP007534DLU
CSB-MP007534DLU
CSB-EP007534DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Didelphis marsupialis virginiana Alpha-2B adrenergic receptor (ADRA2B), partial CSB-YP001389DKL1
CSB-EP001389DKL1
CSB-BP001389DKL1
CSB-MP001389DKL1
CSB-EP001389DKL1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macaca radiata Zona pellucida sperm-binding protein 2 (ZP2), partial CSB-YP027120MOY1
CSB-EP027120MOY1
CSB-BP027120MOY1
CSB-MP027120MOY1
CSB-EP027120MOY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Insulin-like 3 (INSL3), partial CSB-YP011747BO
CSB-BP011747BO
CSB-MP011747BO
CSB-EP011747BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Callithrix jacchus Cytochrome P450 1A2 (CYP1A2), partial CSB-YP006396CYL
CSB-EP006396CYL
CSB-BP006396CYL
CSB-MP006396CYL
CSB-EP006396CYL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carassius auratus Cytochrome c oxidase subunit 2 (mt-co2), partial CSB-YP015073DQG1
CSB-EP015073DQG1
CSB-BP015073DQG1
CSB-MP015073DQG1
CSB-EP015073DQG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Carassius auratus NADH-ubiquinone oxidoreductase chain 6 (MT-ND6), partial CSB-YP015082DQG1
CSB-EP015082DQG1
CSB-BP015082DQG1
CSB-MP015082DQG1
CSB-EP015082DQG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lemur catta NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), partial CSB-YP015076LOK
CSB-EP015076LOK
CSB-BP015076LOK
CSB-MP015076LOK
CSB-EP015076LOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macropus eugenii NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), partial CSB-YP015076MPE
CSB-EP015076MPE
CSB-BP015076MPE
CSB-MP015076MPE
CSB-EP015076MPE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Notoryctes typhlops NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), partial CSB-YP015076NHW
CSB-EP015076NHW
CSB-BP015076NHW
CSB-MP015076NHW
CSB-EP015076NHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Zaglossus bruijni NADH-ubiquinone oxidoreductase chain 1 (MT-ND1), partial CSB-YP015076ZAR1
CSB-EP015076ZAR1
CSB-BP015076ZAR1
CSB-MP015076ZAR1
CSB-EP015076ZAR1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Addax nasomaculatus Cytochrome b (MT-CYB), partial CSB-YP015075AXM
CSB-EP015075AXM
CSB-BP015075AXM
CSB-MP015075AXM
CSB-EP015075AXM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rupicapra rupicapra Cytochrome b (MT-CYB), partial CSB-YP015075ROV
CSB-EP015075ROV
CSB-BP015075ROV
CSB-MP015075ROV
CSB-EP015075ROV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Capra falconeri Cytochrome b (MT-CYB), partial CSB-YP015075CZY
CSB-EP015075CZY
CSB-BP015075CZY
CSB-MP015075CZY
CSB-EP015075CZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>